These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2010-022486-10||A multicentre, randomised, double-blind, placebo-controlled, dose-finding phase II clinical study to evaluate the efficacy of two different doses of MT-102 administered over a sixteen week period in s...||not-yet-due|
|Exempt, with results||2012-001067-79||A Clinical Study Of ColoAd1 Administered by Sub-Acute Fractionated Intravenous Injection: Dose Escalation in Metastatic Epithelial Solid Tumours and Randomised Controlled Trial in Metastatic Colorecta...||2016-04-29||not-yet-due|
|Exempt, with results||2013-001276-38||A Clinical Study Of ColoAd1 Administered Intraperitoneally: Dose Finding and Proof of Concept in Platinum-Resistant Epithelial Ovarian Cancer Estudio clínico de ColoAd1 (INN: EnAd) administrado por...||not-yet-due|
|Listed as ongoing, but also has a completion date||2016-004777-40||A multicentre observational study for the long term follow up of subjects that have been treated with enadenotucirev during interventional clinical trial||2020-09-07||bad-data|